QR-koodi

Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma

This study aimed to explore the effectiveness and safety of <i>Myxoma virus</i> (MYXV) in MM cell lines and primary myeloma cells obtained from patients with multiple myeloma. Myeloma cells were isolated from MM patients and cultured. MYXV, lenalidomide, and bortezomib were used in MM cells. The cyt...

Täydet tiedot

Tallennettuna:
Päätekijät: Alpay Yeşilaltay, Dilek Muz, Berna Erdal, Türker Bilgen, Bahadır Batar, Burhan Turgut, Birol Topçu, Bahar Yılmaz, Burcu Altındağ Avcı
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2024-01-01
Sarja:Pathogens
Aiheet:
multiple myeloma
oncolytic virus
myxoma virus
lenalidomide
bortezomib
Linkit:https://www.mdpi.com/2076-0817/13/1/72
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia